Associated Banc Corp Sells 3,900 Shares of The Allstate Co. (NYSE:ALL)

Associated Banc Corp decreased its position in shares of The Allstate Co. (NYSE:ALL) by 3.3% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 115,716 shares of the insurance provider’s stock after selling 3,900 shares during the quarter. Associated Banc Corp’s holdings in Allstate were worth $21,946,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of ALL. SPC Financial Inc. lifted its position in Allstate by 3.6% during the 3rd quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider’s stock worth $297,000 after acquiring an additional 54 shares during the period. Lake Street Advisors Group LLC boosted its position in Allstate by 1.8% in the 3rd quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider’s stock worth $596,000 after purchasing an additional 54 shares in the last quarter. Abacus Planning Group Inc. grew its stake in shares of Allstate by 2.4% during the 3rd quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider’s stock worth $458,000 after purchasing an additional 56 shares during the period. Chicago Partners Investment Group LLC grew its stake in shares of Allstate by 1.3% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock worth $893,000 after purchasing an additional 59 shares during the period. Finally, Carmichael Hill & Associates Inc. increased its holdings in shares of Allstate by 15.0% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock valued at $87,000 after purchasing an additional 60 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.

Allstate Trading Up 0.1 %

NYSE:ALL traded up $0.27 during mid-day trading on Monday, reaching $204.07. The company’s stock had a trading volume of 42,628 shares, compared to its average volume of 1,537,111. The company’s fifty day simple moving average is $191.41 and its two-hundred day simple moving average is $177.90. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The Allstate Co. has a twelve month low of $134.17 and a twelve month high of $205.35. The stock has a market cap of $54.04 billion, a P/E ratio of 13.20, a P/E/G ratio of 1.81 and a beta of 0.48.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same period last year, the company earned $0.81 EPS. The firm’s quarterly revenue was up 14.7% on a year-over-year basis. On average, equities analysts predict that The Allstate Co. will post 16.07 EPS for the current year.

Allstate Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a yield of 1.80%. The ex-dividend date is Friday, November 29th. Allstate’s dividend payout ratio (DPR) is presently 23.83%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on ALL. Wells Fargo & Company lifted their price target on shares of Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 5th. Jefferies Financial Group raised their price target on shares of Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Raymond James increased their price objective on Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. JPMorgan Chase & Co. increased their target price on shares of Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. Finally, Keefe, Bruyette & Woods boosted their price target on shares of Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $214.19.

Insider Buying and Selling

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This represents a 57.06 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 1.80% of the stock is currently owned by corporate insiders.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.